Are There Any Long-Term Studies on Cannabis Use for AS? 

As a chronic inflammatory condition, ankylosing spondylitis (AS) requires equally long-term treatment plans. Given the growing interest in cannabis, some patients are curious about what will happen if it is used regularly rather than only as a supplement to AS treatment. Are there extended studies to guide such decisions? 

This article examines the state of the science today and what long-term cannabis research shows, particularly in relation to AS use. 

Why Long-Term Data Matters in Chronic Conditions 

AS is a chronic illness. It gradually gets worse over decades, and to manage symptoms and slow spinal fusion, long-term medication and physical treatment are frequently needed. Although crucial, short-term symptom relief is only one aspect of the situation. 

Long-term data matters for several reasons: 

• To determine whether cannabis’s therapeutic effects last over time   

• To identify any cumulative negative consequences, like dependency or cognitive decline  

• To make sure cannabis doesn’t inadvertently conceal the course of a disease, postponing necessary treatment  

Patients and physicians are forced to make educated guesses in the absence of solid AS safety data from long-term trials. 

What We Know from Long-Term Cannabis Research in General 

Despite a lack of AS-specific data, more comprehensive studies on chronic cannabis use provide some useful information: 

• Impact on cognition: Long-term use, particularly of high-THC strains, has been associated with memory problems, a shorter attention span, and poor decision-making, especially when heavy or early-onset use occurs.  

• Risks to mental health: The relationship between cannabis and anxiety, depression, and, in rare instances, psychosis is a topic of continuous discussion. Long-term exposure can make people more vulnerable, especially those who are already at risk.  

• Physical health: Vapourising or consuming edibles may help to mitigate the respiratory problems linked to smoking cannabis. Although less research has been done, cardiovascular effects are concerning for older adults. 

• Tolerance and diminishing returns: As time passes, users might require more to get the same result, raising the possibility of dependency or adverse effects. 

Even though they are not AS specific, these extended cannabis studies point out trends that anyone thinking about long-term use should take note of. 

Are There Long-Term Studies Specific to AS? 

There aren’t any extensive, long-term studies that only look at cannabis use in AS patients now. Most of the current research is: 

• Brief time frame: at most a few weeks to months. 

• Mixed cohorts: The results of AS are frequently muddled by its association with more general conditions like arthritis or chronic pain. 

• Anecdotal or observational: Patient feedback and surveys offer varying degrees of subjective accounts of pain alleviation, better sleep, and less dependence on painkillers, but they lack clinical rigour. 

A large research gap is thus created. AS use of cannabis remains under-examined, particularly for those considering it as a prolonged therapy. 

Key Concerns for Long-Term Use in AS Patients 

Several condition-specific concerns come into play: 

• Masking disease activity: Patients may fail to notice symptoms of disease progression if cannabis effectively numbs pain. If treatment is postponed, irreversible changes to the spine may occur.  

• Interference with prescribed medication: Cannabis may change the way biologics and other medications are metabolised, which could change how effective they are. 

• Mental fatigue or apathy: A long-term cannabis habit may affect motivation, exercise compliance, or the emotional fortitude required to manage a chronic illness. 

• Dependency risk: Especially for people who self-medicate without a doctor’s supervision.  

These dangers highlight the necessity of clear AS safety data and ongoing interaction with healthcare providers. 

Final Thoughts 

Do long-term studies on cannabis for AS exist, then? Not yet, not in the reliable, disease-specific format required to confidently guide use for the rest of one’s life. Research on Chronic cannabis effects does provide helpful hints. While highlighting the possible advantages, it also raises important issues. Patients should proceed cautiously with long-term use of cannabis unless extended AS studies are conducted.  

For those who are thinking about using cannabis to treat their AS: 

•  Begin with medical advice.  

•  Keep a careful eye on the effects over time.  

•  Consider potential long-term trade-offs against any apparent benefits.  

Careful, evidence-based treatment is necessary for chronic conditions. Furthermore, although cannabis might be useful, its role in the long-term treatment of AS is still up for debate. Decisions regarding medical cannabis for ankylosing spondylitis should be discussed with a healthcare provider, just like with any other therapy. Get started with a medical review at LeafEase